The European Cannabis Report: 8th Edition, 2023 provides the latest information and analysis on the development of the cannabis markets across Europe. Included in the report are deep dives into all key sectors and geographic regions in the European cannabis industry, with many data sources which have been exclusively obtained by Prohibition Partners, or else remain un-reported to date.
The European medical cannabis industry has seen steady growth over the past year and it is projected to reach over €550 million in sales by the end of this year. The UK is set to become the second-largest European market over this time, as has been long-predicted by analysts.
The European CBD market remains complex, and in some aspects opaque, but increasingly the picture is becoming clearer. The normalisation of various channels of the industry is slowly moving forward, though the wait for novel food authorisations continues. The combined market size* of all CBD categories in 2023 is over €2 billion.
Four European countries are in the process of developing regulatory models for an adult-use cannabis market; Germany, Czech Republic, Switzerland and the Netherlands. These early adopters are likely to set a precedent for other countries to follow, and may well form the blueprints for a European adult-use cannabis market.
Expert interviews
- Dr. Chiara Liberati, Italy
- Dr. Iris Pleyer, Switzerland
- Dr. Mery Penya, Spain
Country overviews
- Italy
- Czech Republic
- Denmark
- Germany
- Ireland
- Malta
- Portugal
- Switzerland
- UK
- Poland
- Netherlands
Table of Contents
- Medical cannabis
- Legal and regulatory
- Expert interviews
- Supply chain
- Business and financial overview
- CBD
- Novel Foods
- Testing and analysis
- European CBD survey
